Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993752.RAcRQ-I1hKyP_URXelZkJCsybY9kPlFyjQ644iDcPBMCk130_provenance.
• NP1000122.RAcqFQPqZZXlRmzRC_e6zoeTPhJoLEIHhoyZGOEok762U130_assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1000122.RAcqFQPqZZXlRmzRC_e6zoeTPhJoLEIHhoyZGOEok762U130_provenance.
• assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP850234.RAWOu38LONXTrHQ8MSmLknsu1gXJU8o2zVkb2mrROoDQM130_assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850234.RAWOu38LONXTrHQ8MSmLknsu1gXJU8o2zVkb2mrROoDQM130_provenance.
• NP850235.RATrhnu2EgiAlZpfmsuwcy0NmJ5ZT9JlnM68VMqsm1pQA130_assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850235.RATrhnu2EgiAlZpfmsuwcy0NmJ5ZT9JlnM68VMqsm1pQA130_provenance.
• NP850237.RAblmvx5dNdNTgKqf7APmb6k6YNGoquQz-egqSUxqK_iw130_assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850237.RAblmvx5dNdNTgKqf7APmb6k6YNGoquQz-egqSUxqK_iw130_provenance.
• NP850242.RAYalIfFhjEotI6JF6Wnd0VDHrvxY61jj4matJZdY0u1g130_assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850242.RAYalIfFhjEotI6JF6Wnd0VDHrvxY61jj4matJZdY0u1g130_provenance.
• assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP995543.RAtvdvSKNHCApNpt0GbTXf3F4fclKpk_BwLitxChn-_70130_assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995543.RAtvdvSKNHCApNpt0GbTXf3F4fclKpk_BwLitxChn-_70130_provenance.
• NP993680.RAE-1TcGkjtXue_HqYUzaIbdfGZ7gaRANfQaRGoZZAKyw130_assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993680.RAE-1TcGkjtXue_HqYUzaIbdfGZ7gaRANfQaRGoZZAKyw130_provenance.
• NP993655.RAxkIX5j6bRv_Fky5dFeiVAvtlQ3qQD0zEacpqdcJnPB0130_assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993655.RAxkIX5j6bRv_Fky5dFeiVAvtlQ3qQD0zEacpqdcJnPB0130_provenance.
• NP993720.RAxqr0GFczjyDUIW4ch52h01tt68RHI41w8o4NHoS5_WQ130_assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP993720.RAxqr0GFczjyDUIW4ch52h01tt68RHI41w8o4NHoS5_WQ130_provenance.
• NP850233.RAFyqJLIvhNFDV-Gl_YJIRIW2-Y5gktIHJLRdjVQsYSAk130_assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850233.RAFyqJLIvhNFDV-Gl_YJIRIW2-Y5gktIHJLRdjVQsYSAk130_provenance.
• NP850236.RAMfRhMxRFB-AFUGnScw3LoZ336E_0xgfZNgBJ5TfvOO8130_assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850236.RAMfRhMxRFB-AFUGnScw3LoZ336E_0xgfZNgBJ5TfvOO8130_provenance.
• NP850238.RAHlGqmfCn-rLAlGNBzYnybpCYi3M6fwVfJH_EpP8Lu-c130_assertion description "[The relative concentrations of breast cancer-associated miR10b, miR34a, miR141 and miR155 were measured in the blood serum of 89 patients with primary breast cancer (M0, n = 59) and metastatic disease (M1, n = 30), and 29 healthy women by a TaqMan MicroRNA Assay.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850238.RAHlGqmfCn-rLAlGNBzYnybpCYi3M6fwVfJH_EpP8Lu-c130_provenance.